Loading...
Recro Pharma, Inc.
REPH•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$2.09
$-0.01(-0.48%)
Recro Pharma, Inc. (REPH) Quarterly Earnings Reports & Financial Results
Analyze Recro Pharma, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Recro Pharma, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
Recro Pharma, Inc. (REPH) Quarterly Earnings Details
Detailed breakdown of Recro Pharma, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.